Podszus T h, Peter J H, Völger K D, Zilles P
Abteilung Poliklinik, Universität Marburg/Lahn.
Fortschr Med. 1991 Jun 30;109(19):403-6.
In twelve patients with chronic cardiac insufficiency (NYHA II-III), the effect of a fixed combination of drugs (160 mg verapamil/50 mg triamterene/25 mg hydrochlorothiazide) on cardiac hemodynamics was studied over a period of four weeks. During the course of treatment, the arterial blood pressure decreased from 145 +/- 16/93 +/- 9 mmHg to 133 +/- 18/86 +/- 14 mmHg, and the heart rate from 79 +/- 13 to 75 +/- 12 beats/min. Exercise blood pressure (900 watts) decreased from 180 +/- 22/104 +/- 14 mmHg to 158 +/- 25/96 +/- 17 mmHg and the heart rate from 104 +/- 14 to 100 +/- 16 beats per min. After treatment, a decrease in pulmonary arterial pressure and resting pulmonary capillary wedge pressure (PPA:-2.3 mmHg, PPC:-1.4 mmHg) and in exercise pressure (PPA:-8.5 mmHg, PPC:-6.6 mmHg) was established. Clinically relevant changes in cardiac output and cardiac index were not observed. The subjective symptoms (NYHA stage) were improved in eight patients. Combination treatment would appear suitable for patients with mild-to-moderate cardiac insufficiency.
对12例慢性心功能不全(纽约心脏协会II - III级)患者,研究了固定复方药物(160毫克维拉帕米/50毫克氨苯蝶啶/25毫克氢氯噻嗪)在四周内对心脏血流动力学的影响。在治疗过程中,动脉血压从145±16/93±9毫米汞柱降至133±18/86±14毫米汞柱,心率从79±13次/分钟降至75±12次/分钟。运动血压(900瓦)从180±22/104±14毫米汞柱降至158±25/96±17毫米汞柱,心率从104±14次/分钟降至100±16次/分钟。治疗后,肺动脉压和静息肺毛细血管楔压降低(肺动脉压:-2.3毫米汞柱,肺毛细血管楔压:-1.4毫米汞柱),运动时压力也降低(肺动脉压:-8.5毫米汞柱,肺毛细血管楔压:-6.6毫米汞柱)。未观察到心输出量和心脏指数的临床相关变化。8例患者的主观症状(纽约心脏协会分级)得到改善。联合治疗似乎适用于轻至中度心功能不全患者。